2024 Public Comment | Considerations for Generating Clinical Evidence from Oncology Multiregional Clinical Development Programs; Guidance for Industry Read more
2024 White Paper | Framework for Integrating Change in ctDNA Levels in Advanced Cancer Clinical Trials to Support Meta-analyses for Intermediate Endpoint Validation View PDF
2024 White Paper | Enhancing Study Designs and Interpretation of Interim Overall Survival Data in Oncology Trial View PDF
2024 Peer Review | An Analysis of 20 Independently Performed Assays to Measure Homologous Recombination Deficiency (HRD) in Ovarian Cancer: Findings from the Friends’ HRD Harmonization Project Read more
2024 Peer Review | Bridging research and practice: enhancing regulatory decisions with pragmatic clinical trials in oncology Read more
2024 Peer Review | Evaluation of Real-World Tumor Response Derived From Electronic Health Record Data Sources: A Feasibility Analysis in Patients With Metastatic Non–Small Cell Lung Cancer Treated With Chemotherapy Read more
2024 Public Comment | Cancer Clinical Trial Eligibility Criteria: Washout Periods and Concomitant Medications Read more
